Technology | June 06, 2010

Biocompatible Gold Markers Track Tumors for IGRT

June 7, 2010 - One of the biggest challenges in image-guided treatments is tissue location. To help guide visibility, new biocompatible pure gold implanted markers are designed to identify the location of normal or diseased tissue for future treatments, including image-guided radiation therapy (IGRT).

The markers, FlexiMarc and FlexiCoil, used primarily for IGRT, are the first implanted fiducials designed with image projection and marker stability as the primary objectives. Unique node-based technology projects a non-biological image providing the best reference for accurate localization. Both the human eye and software programs can identify FlexiMarc and FlexiCoil.

FlexiMarc’s clearly definable nodes and endpoints project a non-biological image for better automated registration or point based localization. FlexiMarc is available in two or three node variations; nodes are fixed 10 mm apart, are 3 mm long and are available in 0.9 and 1.2 mm diameters.

FlexiCoil was designed with the same imaging advantages as FlexiMarc, but the nodes are placed inside a pure gold coil. FlexiCoil is constructed of a flexible pure gold coil, and is available in 10 and 20 mm lengths. 30 mm lengths will be available shortly. FlexiCoils are currently available with 0.9 and 1.2 mm diameters, and smaller diameter markers are in development. Nodes are placed at each end of the coil, making it simple to locate and determine the exact end of the line.

For more information: www.civco.com

Related Content

Insightec Announces Expanded Reach of MR-Guided Focused Ultrasound
News | Focused Ultrasound Therapy | August 22, 2017
Insightec announced recently that worldwide adoption of magnetic resonance (MR)-guided focused ultrasound continues to...
UCLA Study Offers Roadmap to Personalized Therapies for Sarcoma
News | Oncology Diagnostics | August 22, 2017
A new UCLA study is the first to identify patient and tumor characteristics that predict the successful creation of...
Sponsored Content | Videos | Information Technology | August 22, 2017
Melissa Martin, MS, president of the American Association of Physicists in Medicine (AAPM), discusses her vision of t
Sponsored Content | Videos | Proton Therapy | August 21, 2017
Mark Pankuch, Ph.D., director of medical physics at the Northwestern Medicine Chicago Proton Center, discusses the cl
Summit Cancer Center-Boise Treats First Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | August 21, 2017
Accuray Inc. and the Summit Cancer Center-Boise announced that the center is now treating patients with the Radixact...
MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Overlay Init